Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation
Authors:
- 3 February 2000
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 190 (2) , 184-189
Abstract
The mechanisms of tissue damage in ulcerative colitis and Crohn's disease may reflect disordered humoral or cell‐mediated effector mechanisms, respectively. Mucosal biopsies from untreated inflammatory bowel disease patients and normal controls were analysed for the expression of granzyme B, a cytotoxic effector molecule specifically associated with cell‐mediated immunity, and for regulatory cytokines. Messenger RNA (mRNA) was analysed by reverse transcription‐polymerase chain reaction and enzyme‐linked oligonucleotide chemiluminescence assay. Mucosal biopsies were analysed by immunohistochemistry for granzyme B protein and lymphocyte markers and for the presence of apoptotic cells by terminal deoxynucleotidyl transferase end labelling. Granzyme B mRNA was elevated in Crohn's disease, but not in ulcerative colitis or control mucosal biopsies. Granzyme B mRNA levels correlated with interferon gamma mRNA levels in Crohn's disease. Granzyme B was expressed in CD3+, CD8+ T cells in the lamina propria of Crohn's disease mucosa and there were significantly more apoptotic cells in the lamina propria in Crohn's disease. In conclusion, granzyme B‐expressing T lymphocytes are present in the focal mucosal lesions of Crohn's disease, together with spatially related apoptotic cell death. These results support the hypothesis that T‐cell‐mediated cytotoxic effector mechanisms may play a role in Crohn's disease. Copyright © 2000 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Th1-Th2: Reliable paradigm or dangerous dogma?Immunology Today, 1997
- Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis In VivoAnnual Review of Immunology, 1996
- Preferential Activation of CD4+Vβ5.2/5.3+Intestinal Intraepithelial Lymphocytes in the Inflamed Lesions of Crohn's DiseaseClinical Immunology and Immunopathology, 1996
- Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)Clinical and Experimental Immunology, 1995
- Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral bloodClinical and Experimental Immunology, 1995
- Analysis of γδ region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometryClinical and Experimental Immunology, 1995
- T cell receptor repertoire and mitotic responses of lamina propria T lymphocytes in inflammatory bowel diseaseClinical and Experimental Immunology, 1994
- Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cellsCell, 1994
- Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cellsImmunology Today, 1994
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.Journal of Cell Biology, 1992